Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies - 06/12/18
Doi : 10.1016/j.jaci.2018.08.010
Rebecca A. Marsh, MD a 
, Kyle M. Hebert, MS b, Daniel Keesler, BS b, Jaap J. Boelens, MD, PhD c, Christopher C. Dvorak, MD d, Michael J. Eckrich, MD, MPH e, Neena Kapoor, MD f, Suhag Parikh, MD g, Mary Eapen, MD b
, Kyle M. Hebert, MS b, Daniel Keesler, BS b, Jaap J. Boelens, MD, PhD c, Christopher C. Dvorak, MD d, Michael J. Eckrich, MD, MPH e, Neena Kapoor, MD f, Suhag Parikh, MD g, Mary Eapen, MD b a Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, Ohio
b Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wis
c SCT and Cellular Therapy Program, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
d Division of Pediatric Allergy, Immunology & Bone Marrow Transplantation, Benioff Children's Hospital, University of California San Francisco, San Francisco, Calif
e Pediatric Blood and Marrow Stem Cell Transplantation Program, Texas Transplant Institute, San Antonio, Tex
f Blood and Marrow Transplant Laboratory, Children's Hospital of Los Angeles, Los Angeles, Calif
g Divison of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, NC
| The CIBMTR is supported primarily by Public Health Service Grant 5U24-CA076518 from the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases; by the NHLBI and NCI (grant no. 5U10HL0692940); a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/Department of Health and Human Services); and the Office of Naval Research (grant nos. N00014-15-1-0848 and N00014-16-1-2020). The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, Health Resources and Services Administration, or any other agency of the US government. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 6
P. 2004-2007 - décembre 2018 Retour au numéro
Article précédent
- Breast-feeding and delivery mode modify the association between maternal atopy and childhood allergic outcomes
- Alexandra Rene Sitarik, Nena Sabri Kasmikha, Haejin Kim, Ganesa Wegienka, Suzanne Havstad, Dennis Ownby, Edward Zoratti, Christine Cole Johnson
- Coated microneedle-based cutaneous immunotherapy prevents Der p 1–induced airway allergy in mice
- Akhilesh Kumar Shakya, Chang Hyun Lee, Harvinder Singh Gill
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?